Epco Hasker

Epco Hasker is a Researcher specializing in Mycobacterial Diseases and Neglected Tropical Diseases, affiliated with the University of Antwerp and the Institute of Tropical Medicine (ITM) Antwerp. As Unit Head, they lead research on Human African Trypanosomiasis, Visceral Leishmaniasis, Tuberculosis, and Leprosy. Their work combines epidemiological analysis, diagnostic tool development, and public health interventions.

Educational background includes a Doctorate (PhD) and Medical Doctor (MD) qualifications, though specific institutions are not detailed. Research focuses on disease transmission dynamics, elimination strategies, and drug accessibility. They have contributed to over 115 publications and lead high-impact projects like ZeroLeprosyRoadMap (Pakistan) and StrogHAT (Gambiense HAT elimination).

Key projects include evaluating bedaquiline-enhanced leprosy prophylaxis (Comoros Islands), cost analyses of vector control (DRC), and serological surveillance for post-elimination monitoring. Collaborations span global institutions like the Bill & Melinda Gates Foundation and the European & Developing Countries Clinical Trials Partnership.

Recent publications emphasize leprosy transmission interruption (Leprosy Review, 2025), HAT diagnostic tool validation (Tropical Medicine and International Health, 2025), and fexinidazole accessibility challenges (Lancet Global Health, 2025). Their work bridges clinical research and policy to address neglected tropical diseases in resource-limited settings.